Home Securities Fraud Valeant Pharmaceuticals Drug Cost Inflation Litigation

Valeant Pharmaceuticals Drug Cost Inflation Litigation

Between 2013 and 2015, Valeant Pharmaceuticals, now known as Bausch Health Companies Inc., allegedly misled shareholders about price gouging, kickbacks, and other deceptive business strategies, including a secret network of pharmacies to inflate drug prices and sales. These practices led to massive financial losses for investors, culminating in a $1.2 billion securities class action settlement, one of the largest in U.S. history.

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Last updated: Feb 04, 2025
Valeant Pharmaceuticals Drug Cost Inflation Lawsuit

What’s on this page:

Firm News

July 14, 2025
Seeger Weiss Receives Multiple Honors at American Lawyer Media’s Elite Trial Lawyers 2025

Seeger Weiss received multiple honors at American Lawyer Media’s Elite Trial Lawyers 2025, with the firm named as the Products Liability Practice Group of the Year and senior partner Dave Buchanan receiving the prestigious Lifetime Achievement Award. The Products Liability Practice Group of the Year award recognizes Seeger Weiss’ exceptional work in complex product liability […]

Read More
July 2, 2025
Seeger Weiss Attorneys Publish Article on Whistleblower Protections in Trial Magazine

Seeger Weiss attorneys Stephen A. Weiss and Justin M. Smigelsky have published an article titled “Sounding the Alarm” in the July 2025 issue of Trial Magazine, the publication of the American Association for Justice. The article examines strategies for protecting whistleblowers in False Claims Act cases, drawing from their representation in United States v. Stimwave […]

Read More
June 12, 2025
Seeger Weiss and Partners Recognized in the Chambers 2025 USA Guide

Seeger Weiss is proud to announce that the firm—alongside partners Christopher Seeger, David Buchanan, Ben Barnett, and Parvin Aminolroaya—has been recognized in the newly released Chambers 2025 USA Guide. This marks the fifth consecutive year that Seeger Weiss has been recognized by Chambers USA. For over three decades, Chambers has been a trusted authority in […]

Read More
June 10, 2025
Ten Seeger Weiss Attorneys Named to Lawdragon’s 2025 500 Leading Plaintiff Financial Lawyers List

We are proud to announce that ten Seeger Weiss attorneys have been selected to Lawdragon’s 2025 Leading Plaintiff Financial Lawyers guide list, which honors attorneys who represent plaintiffs in complex financial litigation. Congratulations to Parvin Aminolroaya, Christopher Ayers, Ben Barnett, David R. Buchanan, Steven Daroci, Shauna Itri, Jeremy Kasha, Jennifer Scullion, Christopher Seeger, and Stephen […]

Read More